logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Treatmentresistant Depressive Disorder

    FiltersReset Filters
    6 results

    • fluoxetine

      (Fluoxetine Hydrochloride)
      Aurobindo Pharma Limited
      Usage: Fluoxetine capsules are indicated for the acute and maintenance treatment of Major Depressive Disorder, Obsessive Compulsive Disorder, Bulimia Nervosa, and Panic Disorder. Additionally, in combination with Olanzapine, they treat depressive episodes in Bipolar I Disorder and treatment-resistant depression.

    • fluoxetine

      (Fluoxetine)
      Cadila Pharmaceuticals Limited
      Usage: Fluoxetine capsules are indicated for treating Major Depressive Disorder, Obsessive Compulsive Disorder, Bulimia Nervosa, and Panic Disorder. They can be combined with Olanzapine for Bipolar I Disorder and Treatment Resistant Depression. Monotherapy is not approved for Bipolar I or treatment-resistant cases.

    • olanzapine

      (Olanzapine)
      Ascend Laboratories, LLC
      Usage: Oral olanzapine is indicated for treating schizophrenia and bipolar I disorder (acute manic or mixed episodes). It may be used alone or as an adjunct to lithium or valproate. Additionally, it's indicated in combination with fluoxetine for depressive episodes in bipolar I disorder and treatment-resistant depression.

    • olanzapine

      (Olanzapine)
      Macleods Pharmaceuticals Limited
      Usage: Olanzapine orally disintegrating tablets are indicated for the treatment of schizophrenia, bipolar I disorder (both manic/mixed episodes and as adjunctive therapy), depressive episodes associated with bipolar I disorder (in combination with fluoxetine), and treatment-resistant depression (also with fluoxetine). Caution is advised in pediatric patients due to potential risks.

    • olanzapine

      (Olanzapine)
      Teva Pharmaceuticals USA, Inc.
      Usage: Olanzapine orally disintegrating tablets are indicated for the treatment of schizophrenia and bipolar I disorder (manic or mixed episodes). Additionally, they are used in combination with fluoxetine for depressive episodes associated with bipolar I disorder and treatment-resistant depression. Efficacy has been demonstrated in clinical trials for both adults and adolescents.

    • olanzapine

      (Olanzapine)
      Cadila Pharmaceuticals Limited
      Usage: Olanzapine is indicated for treating schizophrenia, bipolar I disorder (manic or mixed episodes), acute agitation in schizophrenia and bipolar I mania, and in combination with fluoxetine for depressive episodes in bipolar I disorder and treatment-resistant depression. Use in adolescents requires careful risk assessment due to potential side effects.